DCRI, Verily, and HERO Registry to Support Long-Term Safety Study of COVID-19 Vaccine
Novel Blueprint Leverages Behavioral Economics to Inform Clinical Practice
DCRI researchers have created a blueprint to automatically update clinicians on their prescribing habits and those of their peers.
Survey Designed by DCRI Gains Insight into COVID-19 Preferences
DCRI Faculty Members Recognized as ‘Pioneers’
The annual list, which examined papers published over the last decade, honors researchers who were in the top 1 percent of citations in their fields.
AHA 2020: AHA COVID Registry Sheds Light on Pandemic’s Impact on Racial Minorities
Two presentations on the American Heart Association COVID Registry shared data about COVID-19 hospitalizations collected from over 100 hospitals.
DCRI’s CEC Group Contributes to AHA Late-Breakers
AHA 2020: RIVER Shows Rivaroxaban Safe for Patients with Bioprosthetic Valves
AHA 2020: GALACTIC-HF Finds Investigational Therapy to be Effective
PROVIDE-HF Finds Early Improvements in Quality of Life in Patients with Heart Failure Treated with Sacubitril/Valsartan
By evaluating patient-reported and electronic health record data, the pragmatic clinical study adds important real-world evidence to inform clinical practice.
DCRI Selected as U.S. Coordinating Center for NIH ACTIV-1 Trial
The DCRI has received $44 million in funding to examine whether three immune modulators help prevent overactive immune response in moderate or severe cases of COVID-19.